Variable | Glaucoma surgery (N = 12,038) | Non-glaucoma surgery (N = 17,561) |  | ||
---|---|---|---|---|---|
n | Percentage or mean ± SD | n | Percentage or mean ± SD | P Value | |
Age (years) | 12,038 | 68.5 ± 12.4 | 17,561 | 68.8 ± 14.0 | < 0.0001* |
 Category |  |  |  |  | < 0.0001 |
  ≤ 39 | 305 | 2.5 | 719 | 4.1 | < 0.0001 |
  40–49 | 628 | 5.2 | 929 | 5.3 | 0.7910 |
  50–59 | 1488 | 12.4 | 1842 | 10.5 | < 0.0001 |
  60–69 | 3227 | 26.8 | 4168 | 23.7 | < 0.0001 |
  70–79 | 4207 | 34.9 | 6069 | 64.6 | 0.4943 |
  ≥ 80 | 2183 | 18.1 | 3034 | 21.8 | < 0.0001 |
Gender | |||||
 Category |  |  |  |  | < 0.0001 |
  Male | 7032 | 58.4 | 9376 | 53.4 | < 0.0001 |
  Female | 5006 | 41.6 | 8185 | 46.6 | < 0.0001 |
Body mass index (kg/m2) | 12,038 | 22.7 ± 4.3 | 17,561 | 22.2 ± 6.2 | < 0.0001* |
 Category |  |  |  |  | < 0.0001 |
  Thin (< 18.5) | 1076 | 8.9 | 1565 | 8.9 | 0.9504 |
  Normal (≥18.5 < 25) | 7867 | 65.4 | 11,262 | 64.1 | 0.0313 |
  Fat (≥25) | 2969 | 24.7 | 4220 | 24.0 | 0.2144 |
  Not classified | 126 | 1.0 | 514 | 2.9 | < 0.0001 |
Smoking index | 12,038 | 91.3 ± 288.5 | 17,561 | 89.9 ± 290.6 14.0 | 0.9622* |
 Maximum | 0 |  | 0 |  |  |
 Minimum | 5000 |  | 4995 |  |  |
Season | |||||
 Category |  |  |  |  | 0.0303 |
  Spring (April–June) | 3295 | 27.4 | 4659 | 26.5 | 0.1093 |
  Summer (July–September) | 2504 | 20.8 | 3644 | 20.8 | 0.9187 |
  Autumn (October–December) | 2520 | 20.9 | 3922 | 22.3 | 0.0041 |
  Winter (January–March) | 3719 | 30.9 | 5336 | 30.4 | 0.3553 |
Length of stay in hospital | 12,038 | 12.1 ± 6.1 | 17,561 | 8.6 ± 6.0 | < 0.0001* |
 Maximum | 1 |  | 1 |  |  |
 Minimum | 99 |  | 128 |  |  |
Charlson comorbidity index | |||||
 Category |  |  |  |  | 0.4710 |
  Low (0) | 9748 | 81.0 | 14,287 | 81.4 | 0.4135 |
  Medium (1, 2) | 2177 | 18.1 | 3100 | 17.7 | 0.3457 |
  High (3, 4) | 109 | 0.9 | 162 | 0.9 | 0.9013 |
  Very High (≥5) | 4 | 0.0 | 12 | 0.1 | 0.3085 |
Comorbidities | |||||
 Circulatory system | |||||
  Hypertension | 852 | 7.1 | 1428 | 8.1 | 0.0009 |
  Hypotension | 2 | 0.0 | 5 | 0.0 | 0.7820 |
  Ischemic heart disease | 292 | 2.4 | 412 | 2.3 | 0.6694 |
  Heart failure | 82 | 0.7 | 147 | 0.8 | 0.1377 |
  Stroke | 80 | 0.7 | 118 | 0.7 | 1.0000 |
 Metabolic system | |||||
  Diabetes | 1763 | 14.6 | 2386 | 13.6 | 0.0101 |
  Hyperlipidemia | 385 | 3.2 | 575 | 3.3 | 0.7166 |
  Electrolyte disorders | 134 | 1.1 | 232 | 1.3 | 0.1204 |
  Thyroid dysfunction | 14 | 0.1 | 28 | 0.2 | 0.3512 |
  Systemic lupus erythematosus | 10 | 0.1 | 28 | 0.2 | 0.0971 |
 Nervous system | |||||
  Dementia | 18 | 0.2 | 43 | 0.2 | 0.0894 |
  Depression | 56 | 0.5 | 88 | 0.5 | 0.7339 |
  Mental disorders | 1 | 0.0 | 0 | 0.0 | 0.4067 |
 Immune system | |||||
  Cancer | 110 | 0.9 | 155 | 0.9 | 0.8017 |
  Allergies | 981 | 8.1 | 542 | 3.1 | < 0.0001 |
 Gastrointestinal system | |||||
  Peptic ulcer | 181 | 1.5 | 221 | 1.3 | 0.0821 |
  Liver insufficiency/failure | 30 | 0.2 | 35 | 0.2 | 0.3784 |
Concomitant drug | |||||
 Circulatory system | |||||
  Hypertension | 3416 | 28.4 | 5546 | 31.6 | < 0.0001 |
  Hypotension | 36 | 0.3 | 56 | 0.3 | 0.8319 |
  Ischemic heart disease | 2125 | 17.7 | 2625 | 14.9 | < 0.0001 |
  Heart failure | 3656 | 30.4 | 5735 | 32.7 | < 0.0001 |
  Stroke | 2942 | 24.4 | 3053 | 17.4 | < 0.0001 |
 Metabolic system | |||||
  Diabetes | 588 | 4.9 | 635 | 3.6 | < 0.0001 |
  Hyperlipidemia | 777 | 6.5 | 977 | 5.6 | 0.0016 |
  Electrolyte disorders | 1233 | 10.2 | 1907 | 10.9 | 0.0909 |
  Thyroid dysfunction | 78 | 0.6 | 106 | 0.6 | 0.6518 |
  Systemic lupus erythematosus | 303 | 2.5 | 301 | 1.7 | < 0.0001 |
 Nervous system | |||||
  Dementia | 45 | 0.4 | 84 | 0.5 | 0.2084 |
  Depression | 2518 | 20.9 | 2005 | 11.4 | < 0.0001 |
  Mental disorders | 2522 | 21.0 | 2012 | 11.5 | < 0.0001 |
 Immune system | |||||
  Cancer | 9313 | 77.4 | 3997 | 22.8 | < 0.0001 |
  Allergies | 436 | 3.6 | 433 | 2.5 | < 0.0001 |
 Gastrointestinal system | |||||
  Peptic ulcer | 336 | 18.5 | 2450 | 14.9 | < 0.0001 |
  Liver insufficiency/failure | 2230 | 2.8 | 418 | 2.4 | 0.0294 |
Glaucoma types | |||||
 POAG | 4404 | 36.6 | 5628 | 32.0 | < 0.0001 |
 OAG | 4214 | 35.0 | 6300 | 36.0 | 0.1253 |
 NTG | 743 | 6.2 | 1331 | 7.6 | < 0.0001 |
 Not classified | 2677 | 22.2 | 4320 | 24.5 | < 0.0001 |
Glaucoma drug by class | |||||
 PG | 2827 | 23.5 | 3923 | 22.3 | 0.0215 |
 BB | 713 | 5.9 | 1212 | 6.9 | 0.0008 |
 CAI | 1086 | 9.0 | 1445 | 8.2 | 0.0168 |
 ROCKI | 694 | 5.8 | 928 | 5.3 | 0.0771 |
 AA | 1640 | 13.3 | 2317 | 13.2 | 0.7534 |
 AB | 131 | 1.1 | 141 | 0.8 | 0.0130 |
 ABB | 14 | 0.1 | 17 | 0.1 | 0.7151 |
 Sympathomimetics | 12 | 0.1 | 11 | 0.1 | 0.2655 |
 PG/BB fixed combination | 296 | 2.5 | 425 | 2.4 | 0.8479 |
 CAI/BB fixed combination | 713 | 5.9 | 1212 | 6.9 | 0.0008 |
Glaucoma drug by generic name | |||||
 PG | |||||
  Isopropyl Unoprostone | 4 | 0.0 | 13 | 0.1 | 0.2165 |
  Isopropyl Unoprostone GE | 0 | 0.0 | 0 | 0.0 | NA |
  Latanoprost | 917 | 7.6 | 1272 | 7.2 | 0.2309 |
  Latanoprost GE | 152 | 1.3 | 238 | 1.4 | 0.5050 |
  Travoprost | 377 | 3.1 | 550 | 3.1 | 1.0000 |
  Travoprost GE | 0 | 0.0 | 0 | 0.0 | NA |
  Tafluprost | 367 | 3.0 | 669 | 3.8 | 0.0004 |
  Tafluprost GE | 0 | 0.0 | 0 | 0.0 | NA |
  Bimatoprost | 1069 | 8.9 | 1274 | 7.3 | < 0.0001 |
  Bimatoprost GE | 0 | 0.0 | 0 | 0.0 | NA |
 BB | |||||
  Timolol Maleate | 435 | 3.6 | 761 | 4.3 | 0.0020 |
  Timolol Maleate GE | 52 | 0.4 | 73 | 0.4 | 0,8544 |
  Carteolol Hydrochloride | 217 | 1.8 | 367 | 2.1 | 0.0813 |
  Carteolol Hydrochloride GE | 10 | 0.1 | 12 | 0.1 | 0.6687 |
  Betaxolol Hydrochloride | 2 | 0.0 | 5 | 0.0 | 0.7082 |
  Betaxolol Hydrochloride GE | 0 | 0.0 | 1 | 0.0 | 1.0000 |
 CAI | |||||
  Dorzolamide Hydrochloride | 225 | 1.9 | 295 | 1.7 | 0.2243 |
  Dorzolamide Hydrochloride GE | 0 | 0.0 | 0 | 0.0 | NA |
  Brinzolamide | 686 | 5.7 | 914 | 5.2 | 0.0670 |
  Brinzolamide GE | 0 | 0.0 | 0 | 0.0 | NA |
 ROCKI | |||||
  Ripasudil Hydrochloride Hydrate | 694 | 5.8 | 928 | 5.3 | 0.0771 |
  Ripasudil Hydrochloride Hydrate GE | 0 | 0.0 | 0 | 0.0 | NA |
 AA | |||||
  Brimonidine Tartrate | 1604 | 13.3 | 2317 | 13.2 | 0.7534 |
  Brimonidine Tartrate GE | 0 | 0.0 | 0 | 0.0 | NA |
 AB | |||||
  Bunazosin Hydrochloride | 131 | 1.1 | 141 | 0.8 | 0.0130 |
  Bunazosin Hydrochloride GE | 0 | 0.0 | 0 | 0.0 | NA |
 ABB | |||||
  Levobunolol Hydrochloride | 2 | 0.0 | 1 | 0.0 | 0.5705 |
  Levobunolol Hydrochloride GE | 0 | 0.0 | 0 | 0.0 | NA |
  Nipradilol | 13 | 0.1 | 16 | 0.1 | 0.7067 |
  Nipradilol GE | 0 | 0.0 | 1 | 0.0 | 1.0000 |
 Sympathomimetics | |||||
  Dipivefrin Hydrochloride | 12 | 0.1 | 11 | 0.1 | 0.2917 |
  Dipivefrin Hydrochloride GE | 0 | 0.0 | 0 | 0.0 | NA |
 PG/BB fixed combination | |||||
  Lat/Tim | 114 | 0.9 | 211 | 1.2 | 0.0409 |
  Lat/Tim GE | 0 | 0.0 | 0 | 0.0 | NA |
  Lat/Car | 1 | 0.0 | 3 | 0.0 | 0.6560 |
  Lat/Car GE | 0 | 0.0 | 0 | 0.0 | NA |
  Tra/Tim | 141 | 1.2 | 163 | 0.9 | 0.0459 |
  Tra/Tim GE | 0 | 0.0 | 0 | 0.0 | NA |
  Taf/Tim | 41 | 0.3 | 51 | 0.3 | 0.4582 |
  Taf/Tim GE | 0 | 0.0 | 0 | 0.0 | NA |
 CAI/BB fixed combination | |||||
  Dor/Tim | 1519 | 12.6 | 2327 | 13.3 | 0.1133 |
  Dor/Tim GE | 0 | 0.0 | 0 | 0.0 | NA |
  Brinzolamide/Tim | 359 | 3.0 | 547 | 3.1 | 0.5364 |
  Brinzolamide/Tim GE | 0 | 0.0 | 0 | 0.0 | NA |